Literature DB >> 29184712

Asymmetric neuromodulation of motor circuits in Parkinson's disease: The role of subthalamic deep brain stimulation.

Karlo J Lizarraga1,2, Corneliu C Luca2, Antonio De Salles3, Alessandra Gorgulho3, Anthony E Lang1,4, Alfonso Fasano1,4.   

Abstract

Whereas hemispheric dominance is well-established for appendicular motor control in humans, the evidence for dominance in axial motor control is still scarce. In Parkinson's disease (PD), unilateral (UL) onset of appendicular motor symptoms corresponds with asymmetric neurodegeneration predominantly affecting contralateral nigrostriatal circuits. Disease progression yields bilateral and axial motor symptoms but the initial appendicular asymmetry usually persists. Furthermore, there is evidence for hemispheric dominance for axial motor dysfunction in some of these patients. Dopaminergic medications improve appendicular symptoms but can also produce motor complications over time. Once these complications develop, bilateral (BL) deep brain stimulation (DBS) of the subthalamic nuclei (STN) can significantly improve appendicular symptoms while reducing medication doses and motor complications. Conversely, axial motor symptoms remain a significant source of disability, morbidity, and mortality for patients with PD. These axial symptoms do not necessarily improve with dopaminergic therapy, might not respond, and could even worsen after BL-DBS. In contrast to medications, DBS provides the opportunity to modify stimulation parameters for each cerebral hemisphere. Identical, BL-DBS of motor circuits with hemispheric dominance in PD might produce overstimulation on one side and/or understimulation on the other side, which could contribute to motor dysfunction. Several studies based on asymmetry of appendicular motor symptoms already support an initial UL rather than BL approach to DBS in some patients. The response of axial motor symptoms to UL versus BL-DBS remains unclear. Nonetheless, UL-DBS, staged BL-DBS, or asymmetric programming of BL-DBS could also be considered in patients with PD.

Entities:  

Keywords:  Asymmetric neuromodulation; Parkinson's disease; hemispheric dominance; postural instability and gait dysfunction; subthalamic nucleus deep brain stimulation

Year:  2017        PMID: 29184712      PMCID: PMC5680653          DOI: 10.4103/sni.sni_292_17

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


INTRODUCTION

Parkinson's disease (PD) is a chronic neurodegenerative disorder associated with loss of dopaminergic neurons in the nigrostriatal pathways. In the U.S., approximately 1 million people have PD and additional 50,000 are diagnosed each year. The prevalence of PD significantly increases with age, ranging from 41 per 100,000 people in the 40–49 years group to 19 per 1,000 people older than 80 years worldwide.[1857] With the estimated increase in the U.S. population older than 50 years old, the overall PD prevalence of 0.401% in 2005 will increase to approximately 0.535% in the year 2040.[58] Despite promising advances in the understanding of this condition, PD remains a relentlessly progressive condition that significantly impairs motor and nonmotor aspects of daily living. Appendicular motor dysfunction in early PD is usually unilateral (UL) and includes tremor, rigidity, and bradykinesia. Disease progression yields bilateral (BL) and axial motor symptoms, but the initial UL predominance usually persists. Dopaminergic agents can improve appendicular and some axial symptoms; however, they can also produce significant complications over time (fluctuations, dyskinesia). Once these complications develop, BL deep brain stimulation (DBS) of the subthalamic nuclei (STN) is a safe and effective intervention capable of improving appendicular symptoms while reducing medication requirements and motor complications. Axial motor dysfunction in PD includes dysarthria, dysphagia, postural instability, and gait dysfunction (PIGD) including freezing of gait (FOG). These symptoms remain a significant source of morbidity and mortality in PD. They do not necessarily improve with medications, might not respond, and could even worsen with BL STN-DBS.[697778] In this review, we focus on the evidence for hemispheric dominance of appendicular and axial motor control in PD, and the potential effects of modulating these presumably lateralized circuits with unilateral (UL), symmetric, and asymmetric BL STN-DBS.

LATERALIZATION OF NORMAL MOTOR CONTROL

Certain brain functions are predominantly controlled by one hemisphere (i.e., hemispheric dominance or lateralization). For instance, the right (R) hemisphere is dominant for spatial cognition, body schema, proprioceptive control, and action inhibition,[53183] whereas the left (L) is dominant for verbal processing and motor control.[65] This L-sided dominance for motor control is particularly clear in 90% of humans that are R-handed. In L-handed and ambidextrous people, several studies have shown that brain asymmetries are less pronounced, and thus, it is unclear if the R hemisphere is dominant or if there is lack of the usual L-sided dominance.[2640] The mechanism of lateralization for motor control is unknown. Even though a genetic basis could be possible, heritability studies have not been conclusive.[28] Interestingly, this functional segregation might be established during early development, based on the preferential encoding of low-frequency signals representing global information in the R hemisphere, as opposed to high-frequency, local information in the L hemisphere.[3864] The L-sided lateralization for motor control is more evident for distal as opposed to proximal tasks, independent of the performing hand. Although motor dominance can be assessed in terms of preference (hand chosen to move) and/or performance (hand most proficient at the movement), it is also evident during bimanual movements. In this case, the dominant hand usually performs distal, fine movements, whereas the nondominant hand serves proximal, postural purposes.[6572] This pattern is concordant with clinical data suggesting that the L hemisphere is dominant for task-relevant, timing aspects of ballistic, and sequential movements, whereas the R hemisphere is dominant for processing visual and sensory-mediated mechanisms that control final limb position.[682] Though dominance for more proximal and axial motor functions such as posture, balance, and locomotion is not yet well-established, it has been proposed that the R hemisphere controls limb position and posture whereas the L hemisphere controls limb trajectory.[6182] For instance, the R inferior frontal cortex and STN have been implicated in motor inhibition through suppression of thalamocortical signals.[5] Moreover, internal or previously known stimuli appear to trigger L greater than R-sided motor processing, whereas external or novel stimuli might lead to R greater than L-sided motor processing.[31] Hemispheric functional differences for motor control have also been observed during learning. The progressive development of “motor expertise” has been associated with a transition from externally to internally generated movement control, along with a shift from R to L hemispheric activation. This phenomenon might be produced by a progressive reduction in the monitoring of global, spatial, and external features, as well as an increased representation of the local, internal motor program with learning.[1573] Even though locomotion is considered symmetric, functional gait asymmetries have been observed in normal humans.[59] In fact, normal stride length appears to be longer with the R foot. A possible explanation is that the R leg has greater muscle power and dominates gait propulsion, whereas the L leg has greater power absorption and dominates postural stabilization.[5960] Therefore, functional gait asymmetry might be associated with the previously mentioned hemispheric asymmetries for motor control. Nevertheless, leg muscle asymmetries might be predominant and thus the origin of gait asymmetry is still controversial.[5960] Because the functions preferentially carried out by the R hemisphere (visuospatial orientation, action inhibition, posture) are indispensable for movement,[5646572] it has also been proposed that hemispheric lateralization of motor control is a dynamic, “interhemispheric” process during which the functional involvement of both hemispheres can adapt to the type and complexity of the task being performed, as well as to the neurological and attentional status of the performer [Figure 1].[664] For instance, recent studies in patients with longstanding callosotomies replicated the classic finding that each hemisphere processes sensory information independently, as seen in the acute phase, but also found that the outcomes of those perceptual processes can be unified in one consciousness, regardless of the type and laterality of the response (verbal, L hand, or R hand).[55] Remarkably, these patients have less difficulties than normal controls in simultaneously producing bimanual movements with different directions.[25]
Figure 1

Graphic representation of the possible contributions of symmetric bilateral subthalamic stimulation to axial motor deterioration in the context of asymmetric circuits for axial motor control and Parkinson's disease progression. (L: left, R: right, BL: bilateral, PPN/MLR: pedunculopontine nucleus/mesencephalic locomotor region, PMRF: pontomedullary reticular formation)

Graphic representation of the possible contributions of symmetric bilateral subthalamic stimulation to axial motor deterioration in the context of asymmetric circuits for axial motor control and Parkinson's disease progression. (L: left, R: right, BL: bilateral, PPN/MLR: pedunculopontine nucleus/mesencephalic locomotor region, PMRF: pontomedullary reticular formation)

LATERALIZATION OF MOTOR CONTROL IN PARKINSON'S DISEASE

Disease processes such as PD can also produce lateralized dysfunction. In fact, dopaminergic denervation of the striatum in PD begins asymmetrically and gradually becomes BL with disease progression.[37] As a consequence, appendicular motor dysfunction (bradykinesia, tremor, rigidity) usually begins contralateral to the most affected nigrostriatal pathway and later spreads to the opposite side. The cause of this phenomenon is unknown, but there is extensive evidence from clinical, radiological, and pathological studies supporting this initial asymmetry in PD, which can be maintained over the years despite disease progression.[10143981] Even though there is limited evidence, an underlying asymmetry of nigrostriatal pathways associated with motor control dominance could be responsible for or at least contribute to the initial asymmetry in PD.[3041] For instance, the degree of R-handedness was found to increase with L putamen dopaminergic dominance.[14] In the same study, bimanual dexterity in R-handed people with and without PD correlated better with R caudate dominance. Therefore, bimanual movements might depend upon simultaneous L putaminal activation of L hemispheric motor circuits and R caudate inhibition of R-sided circuits.[14] There is also evidence supporting lateralization of axial motor dysfunction in PD, which includes dysarthria, dysphagia, FOG, and PIGD.[1112132329] Even though there is conflicting data,[33] PD patients with L-sided predominant appendicular symptoms at onset have been found to be at higher risk of developing FOG in a large cohort of 250 patients (hazard ratio 1.55).[29] This suggests that R-hemisphere predominant PD is associated with more frequent and earlier derangement of gait control. Interestingly, specific lack of gait coordination and symmetry might be more important than motor control asymmetry for FOG in PD.[56] Given that normal stride length appears to be longer with the R foot,[5960] L-sided predominant PD might make this normal asymmetry more exaggerated by reducing stride length with the L foot. This asymmetry might then explain the higher risk for FOG in L-sided predominant PD. Patients with PD and FOG also appear to have abnormally reduced structural connectivity on diffusion tensor imaging (DTI) and functional MRI (fMRI) signals preferentially affecting R-sided motor circuits during gait imagery tasks.[12235253] In these patients, hypoactive fMRI signals were seen within the BL parieto-occipital, L posterior hippocampal, L cerebellar, and L mesencephalic regions, including the pedunculopontine nucleus/mesencephalic locomotor region (PPN/MLR). Within this network, decreased activation of the R posterior parietal cortex strongly correlated with the severity of gait disturbances.[12] In another fMRI study of patients with PD and FOG, gait imagery of quiet standing, simple forward walking, and complex locomotor tasks showed significantly lower signals in the R pallidum and trends towards lower signals in other R hemisphere regions involved with locomotion (supplementary motor area, PPN/MLR).[5253] These abnormalities within the R hemisphere consistently involve the PPN/MLR, and the executive-attention network including prefrontal and parietal regions.[12235253] A previous single-photon emission CT study also reported that treadmill gait-induced cerebral activity in PD remained low in the R precuneus of the superior parietal lobe when compared to controls.[35] Walking guided by transverse lines increased activation of posterior parietal and cerebellar regions in these PD patients, with greater activation of the R premotor area.[34] In addition, decreased resting-state activity in the R parietal cortex in PD patients with FOG has been described with positron emission tomography.[7] These data, along with other studies that specifically implicate R hemispheric alterations in subjects with PD and FOG,[875] suggest that axial dysfunction in PD is associated with abnormalities of R greater than L hemispheric circuits involved in locomotion [Table 1]. Despite imaging studies being unable to distinguish between excitatory or inhibitory circuits, these findings are concordant with the previously reviewed data pointing towards a possible R-sided hemispheric dominance for axial motor control in humans.[1532617382]
Table 1

Evidence for lateralization of axial dysfunction in patients with Parkinson's disease

Evidence for lateralization of axial dysfunction in patients with Parkinson's disease

NEUROMODULATION OF LATERALIZED MOTOR CIRCUITS IN PARKINSON'S DISEASE

Dopaminergic agents can improve appendicular symptoms in PD; however, they can also produce motor fluctuations and/or dyskinesias over time. Once these complications develop, BL STN-DBS has emerged as a very effective and relatively safe treatment modality for these motor complications. It is especially effective in controlling appendicular symptoms in PD.[164350] Yet, worsening of axial symptoms after BL STN-DBS can occur in almost 20% of patients in the year following implantation.[1921697778] The widespread BL as opposed to UL strategy for initial implantation of the STN is based on limited evidence. Identical DBS of potentially lateralized motor circuits might be unnecessary in all patients and could even contribute to the axial motor deterioration observed in some of them.[20476977] Also, although BL STN-DBS is relatively safe, it might carry higher costs and more peri- and postoperative complications such as confusion and cognitive decline when compared to UL procedures.[4243654] For instance, a recent study suggests that there is higher location variability of the second implanted DBS electrode during BL procedures due to multiple factors, such as brain shift caused by air penetration and/or CSF outflow caused by the first skull penetration. This higher variability was associated with lower threshold for side effects and was predictive of motor outcomes at 1 year.[62] Though there have not been head-to-head comparative trials, a common argument is that BL STN-DBS would allow for greater reduction in dopaminergic medication doses and subsequent improvement in dyskinesia, whereas UL implantation would not permit a similar reduction in medication due to uncontrolled worsening of symptoms on the side contralateral to the nonimplanted hemisphere. Worsening of axial dysfunction after BL STN-DBS has been attributed to the variable combination of disease progression beyond dopaminergic systems and the unwanted spread of electrical fields beyond the STN.[22437677] More recently, interference of BL STN-DBS with potentially asymmetric circuits underlying interlimb coordination during locomotion has been suggested as a cause of FOG.[20] Equal stimulation of these asymmetric motor circuits could cause overstimulation of one hemisphere and/or understimulation of the other hemisphere [Figure 1]. For instance, it has been observed that overstimulation and subsequent extension of the electric field can produce complications such as hypokinesia and FOG, particularly with anteromedial and dorsal spread from the STN.[2276] Furthermore, overstimulation contralateral to the most affected hemibody can impair gait despite improving appendicular symptoms.[2047] In fact, reducing the amplitude of DBS contralateral to the side with the longer stride length improves FOG through normalization of coordination.[20] These improvements could be associated with the reduction of gait asymmetry initially increased by symmetric BL STN-DBS.[565960] Interestingly, different patterns of local field potentials in motor networks have been associated with axial and appendicular symptoms. For instance, PIGD has been associated with decreased beta and increased gamma and alpha/theta bands. In contrast, bradykinesia has been associated with increased beta frequencies.[67] Consequently, DBS could improve bradykinesia but worsen PIGD by decreasing beta activity in these motor circuits. Finally, some studies have suggested that decreasing DBS frequency to 60–80 Hz could ameliorate PIGD in PD after BL STN-DBS (usually programmed with BL frequencies higher than 100 Hz). Bilateral “low-frequency” STN-DBS could be useful for patients who develop side effects associated with “high-frequency” BL STN-DBS, including axial motor dysfunction.[174784] The asymmetric programming of DBS frequencies might also become a therapeutic option for these patients with the availability of new DBS technology. In addition to PIGD, speech dysfunction can also be accelerated after BL STN-DBS in PD.[1976] Interestingly, it has been observed that patients who have a medially-displaced and/or high-voltage DBS electrode over the L hemisphere are at a higher risk for speech deterioration in the year following BL STN-DBS surgery.[76] This side effect could be associated with overstimulation of L-sided dominant circuits associated with verbal control.[65] In contrast to medications, DBS provides the opportunity to modify some stimulation parameters separately for each cerebral hemisphere. In some patients, both appendicular and axial motor improvements achieved with UL and BL STN-DBS are similar.[117179] Several studies have shown that UL STN-DBS can improve motor scores by 20–40% when compared to preoperative scores.[927424668] This motor improvement with UL STN-DBS is mostly related to benefits on the contralateral hemibody, although ipsilateral effects have also been reported.[12366687479] Interestingly, approximately 50% of patients with PD undergoing BL STN-DBS have been found to have a “dominant” STN. This phenomenon was predicted by longer disease duration and tremor predominance.[11] Moreover, basal ganglia phase synchronization studies provide evidence for the existence of interhemispheric networks with lateralized dominant regions. In one of these studies, unilateral motor tasks performed by 4 PD patients with BL STN-DBS led to synchronization of alpha oscillations in both STN. These BL STN alpha oscillations were phase synchronized across hemispheres at the onset of movement, with a flow of synchronization always directed from the R to the L STN, regardless of which side performed the motor task.[13] Finally, UL STN-DBS has been shown to activate BL basal ganglia networks, which is also irrespective of the side of the body that performs the movement.[80] Therefore, optimized neuromodulation of UL “dominant” motor circuits might be able to activate BL networks and ameliorate symptoms bilaterally. Based on the asymmetry of appendicular motor symptoms in PD, several studies support an initial UL as opposed to BL approach to STN-DBS in some patients [Table 2].[4571747980] In a prospective study that followed 82 patients after UL STN-DBS contralateral to the most affected hemibody, only 34% of the patients required contralateral implantation in the following 2 years. Predictors of the need for contralateral DBS were symmetric appendicular motor symptoms, high tremor subscore, and low body weight.[71] Given that motor asymmetry in PD is more pronounced early in the disease, UL implantation might become more frequent in the setting of the recent FDA approval of DBS for earlier PD based on the results of the EARLY-STIM trial.[63]
Table 2

Results of asymmetric neuromodulation with subthalamic DBS in Parkinson's disease

Results of asymmetric neuromodulation with subthalamic DBS in Parkinson's disease Previous studies have suggested that UL and BL DBS can produce similar effects on axial symptoms in PD; however, BL stimulation appears to yield the maximal benefits.[91142454774] Given the extensive BL connections of the PPN/MLR, UL PPN-DBS might be enough to produce bilateral effects, and in fact it has been shown to improve PIGD early after implantation in PD.[485170] Though L vs. R differences were not studied, L PPN-DBS yielded greater improvement in axial symptoms in a small sample.[44] The differential effects of R-sided, L-sided, and BL STN-DBS in the context of potentially lateralized axial motor circuits have not been systematically studied. In a recent pilot study of patients with PD who developed axial motor dysfunction after BL STN-DBS,[47] stride length improved by 5 cm more during R versus L STN-DBS and by 7 cm more during BL versus L STN-DBS. The 2-cm difference in favor of BL versus R STN-DBS was not significant. Other gait parameters such as stride velocity and turning time were similar among BL and both UL STN-DBS conditions; however, motor and gait UPDRS scores improved more with BL versus UL STN-DBS. The differences persisted after controlling for asymmetric PD symptoms. These data are consistent with the theory of R-hemispheric dominance for locomotion and other axial functions. Given the established efficacy of BL STN-DBS and the significant contribution of axial dysfunction to morbidity and mortality in PD patients, it is paramount to identify patients whose axial dysfunction could worsen with BL as opposed to UL or individualized asymmetric programming of BL STN-DBS. A comprehensive presurgical assessment of DBS candidates that includes evaluation of motor lateralization could identify patients who would benefit from an initial UL as opposed to BL DBS paradigm based on both appendicular, axial, and possibly nonmotor symptoms. Although contralateral implantation might be required with disease progression, the initial UL approach could be maintained by asymmetric programming of DBS parameters for each hemisphere (e.g., voltage).[2047] This asymmetric programming could avoid unnecessary stimulation while maximizing the benefits of BL STN-DBS in appendicular dysfunction [Table 2; Figure 1].

CONCLUSIONS

Whereas the L hemisphere appears to be dominant for appendicular movements, there is growing evidence supporting R hemispheric dominance for axial motor control. Recently, theories involving complex interhemispheric relationships are attempting to unify the established models of hemispheric lateralization. In PD, BL STN-DBS is an established treatment modality that can significantly improve appendicular symptoms. Given the usually persistent asymmetry of appendicular symptoms in PD, some patients benefit from an asymmetric approach favoring DBS of the STN contralateral to the worse symptomatic side. Axial symptoms are still a significant contributor to disability, morbidity, and mortality in PD. These symptoms might not respond and can even worsen with BL STN-DBS. The comparative effects of UL or asymmetric programming of BL STN-DBS for axial symptoms have not yet been systematically evaluated, although data consistent with R-sided hemispheric dominance for axial control suggests that both UL and BL STN-DBS could produce similar effects. Thus, an asymmetric approach to STN-DBS implantation or programming could also be considered in PD patients with predominant axial dysfunction to avoid over- or understimulation of potentially asymmetric circuits. The availability of new DBS technology could facilitate the design of individualized asymmetric stimulation parameters that minimize axial impairment while maintaining appendicular symptom control.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  81 in total

1.  Evidence for a dynamic-dominance hypothesis of handedness.

Authors:  Robert L Sainburg
Journal:  Exp Brain Res       Date:  2001-11-22       Impact factor: 1.972

Review 2.  Dynamics of hemispheric specialization and integration in the context of motor control.

Authors:  Deborah J Serrien; Richard B Ivry; Stephan P Swinnen
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

3.  Does dominant pedunculopontine nucleus exist? Probably not.

Authors:  Julie M Hall; Moran Gilat; Simon J G Lewis; James M Shine
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

4.  Does dominant pedunculopontine nucleus exist?

Authors:  Susy Lam; Elena Moro; Yu-Yan Poon; Andres M Lozano; Alfonso Fasano
Journal:  Brain       Date:  2014-08-13       Impact factor: 13.501

5.  Maintaining internal representations: the role of the human superior parietal lobe.

Authors:  D M Wolpert; S J Goodbody; M Husain
Journal:  Nat Neurosci       Date:  1998-10       Impact factor: 24.884

6.  Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait.

Authors:  Brett W Fling; Rajal G Cohen; Martina Mancini; John G Nutt; Damian A Fair; Fay B Horak
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

7.  Is freezing of gait in Parkinson's disease related to asymmetric motor function?

Authors:  Meir Plotnik; Nir Giladi; Yacov Balash; Chava Peretz; Jeffrey M Hausdorff
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

Review 8.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

Review 9.  Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jay L Alberts; Christopher J Hass; Jerrold L Vitek; Michael S Okun
Journal:  Exp Neurol       Date:  2008-07-31       Impact factor: 5.330

10.  Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease.

Authors:  Samer D Tabbal; Mwiza Ushe; Jonathan W Mink; Fredy J Revilla; Angie R Wernle; Minna Hong; Morvarid Karimi; Joel S Perlmutter
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

View more
  10 in total

1.  Management of Pisa syndrome with lateralized subthalamic stimulation.

Authors:  Karlo J Lizarraga; Maryam Naghibzadeh; Alexandre Boutet; Gavin J B Elias; Alfonso Fasano
Journal:  J Neurol       Date:  2018-08-03       Impact factor: 4.849

2.  Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.

Authors:  Chioma Anidi; Johanna J O'Day; Ross W Anderson; Muhammad Furqan Afzal; Judy Syrkin-Nikolau; Anca Velisar; Helen M Bronte-Stewart
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

3.  Effects of Unilateral Stimulation in Parkinson's Disease: A Randomized Double-Blind Crossover Trial.

Authors:  Zhitong Zeng; Linbin Wang; Weikun Shi; Lu Xu; Zhengyu Lin; Xinmeng Xu; Peng Huang; Yixin Pan; Zhonglue Chen; Yun Ling; Kang Ren; Chencheng Zhang; Bomin Sun; Dianyou Li
Journal:  Front Neurol       Date:  2022-01-20       Impact factor: 4.003

4.  Resting-State Functional Connectivity Predicts STN DBS Clinical Response.

Authors:  John R Younce; Meghan C Campbell; Tamara Hershey; Aaron B Tanenbaum; Mikhail Milchenko; Mwiza Ushe; Morvarid Karimi; Samer D Tabbal; Albert E Kim; Abraham Z Snyder; Joel S Perlmutter; Scott A Norris
Journal:  Mov Disord       Date:  2020-11-19       Impact factor: 10.338

5.  The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study.

Authors:  Stanislaw Szlufik; Maria Kloda; Andrzej Friedman; Iwona Potrzebowska; Kacper Gregier; Tomasz Mandat; Andrzej Przybyszewski; Justyna Dutkiewicz; Monika Figura; Piotr Habela; Dariusz Koziorowski
Journal:  Front Neurol       Date:  2018-10-31       Impact factor: 4.003

6.  Combined Unilateral Subthalamic Nucleus and Contralateral Globus Pallidus Interna Deep Brain Stimulation for Treatment of Parkinson Disease: A Pilot Study of Symptom-Tailored Stimulation.

Authors:  Chencheng Zhang; Linbin Wang; Wei Hu; Tao Wang; Yijie Zhao; Yixin Pan; Leonardo Almeida; Adolfo Ramirez-Zamora; Bomin Sun; Dianyou Li
Journal:  Neurosurgery       Date:  2020-11-16       Impact factor: 4.654

7.  The role of brain perivascular space burden in early-stage Parkinson's disease.

Authors:  Ting Shen; Yumei Yue; Shuai Zhao; Juanjuan Xie; Yanxing Chen; Jun Tian; Wen Lv; Chun-Yi Zac Lo; Yi-Cheng Hsu; Tobias Kober; Baorong Zhang; Hsin-Yi Lai
Journal:  NPJ Parkinsons Dis       Date:  2021-02-05

Review 8.  Effects of Deep Brain Stimulation on Postural Trunk Deformities: A Systematic Review.

Authors:  Karlo J Lizarraga; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2019-10-01

Review 9.  Lateralized effects of deep brain stimulation in Parkinson's disease: evidence and controversies.

Authors:  Zhengyu Lin; Chencheng Zhang; Dianyou Li; Bomin Sun
Journal:  NPJ Parkinsons Dis       Date:  2021-07-22

Review 10.  Neurophysiological biomarkers to optimize deep brain stimulation in movement disorders.

Authors:  Daniel Sirica; Angela L Hewitt; Christopher G Tarolli; Miriam T Weber; Carol Zimmerman; Aida Santiago; Andrew Wensel; Jonathan W Mink; Karlo J Lizárraga
Journal:  Neurodegener Dis Manag       Date:  2021-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.